photo
Speaker

Ali Siam

CHIEF BUSINESS OFFICER, CELMATIX, INC.
New York, New York, United States
Ali Siam is Chief Business Officer at Celmatix, where he leads business and strategy development. Ali brings a rare combination of strategic planning and operating experience across functional areas in healthcare and the life sciences. Prior to joining Celmatix, he led corporate strategy, R&D prioritization, portfolio strategy, and due diligence engagements for small to large pharmaceutical, diagnostic, healthcare services, biotech, and institutional investor clients across therapeutic areas as a team leader at L.E.K. Consulting. He also led collaborations with innovators in an atypical modalities-focused partnering team at AbbVie, in addition to roles in Market Access and Marketing across Oncology, Immunology, Infectious Disease, Neuroscience, and Metabolics. Ali also has strategic marketing and R&D experience from his time at Johnson & Johnson and Boston Scientific, and holds an MBA from Boston College and a BS in Mechanical Engineering from Northeastern University.
Speaking In
[Available On-Demand]
Celmatix is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a…